EMJ 6.4 2021

In this issue

Volume 6, Issue 4
Contents
 
Symposium review
12-20 Factor XI Inhibition: The Holy Grail of Haemostasis-Sparing Anticoagulation Kakkar et al.
Interviews
21-24 Evra (Norelgestromin and Ethinyl Oestradiol) and Contraceptive Options Available to Females Today Kubba
26-31 Neurofibromatosis Type 1: Burden of Disease in Patients with Plexiform Neurofibromas Oostenbrink
32-35 Management and Multi-specialty Approach in the Evolving Treatment Landscape of Neurofibromatosis Type 1 Plexiform Neurofibromas Azizi
36-39 Aficamten: A New Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy Olivotto
40-45 Automated Echocardiography Analysis: Expanding Access and Saving Time Lam and Gan
Articles
48-56 A Case of Severe COVID-19 Infection in a Patient with Acute Myeloid Leukaemia: Critical Care Management and a Review of the Literature Gupta et. al
57-65 Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy? Siddiqui et al.
66-75 Identifying Common Biomarkers Between COVID-19 and Commonly Associated Comorbidities Huang
76-86 Current Therapy for Homozygous Familial Hypercholesterolaemia Alonso
87-95 Pasteurella multocida Endocarditis with Septic Arthritis: Case Report and Review of the Literature Carter et al.
96-108 Risk Factors and Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Update Karyampudi et al.
109-117 The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases Kim and Suh
118-128 Cannabinoids in the Treatment of Epilepsy: A Review Zhou et al.
129-132 The Association Between Hypermobility Ehlers–Danlos Syndrome and Other Rheumatologic Diseases Makol
133-138 Cefixime-Induced Hepatitis: A Case Report and Review of Literature Fiani et al.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given